Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 249

1.

Prevalence and risk factors for faecal carriage of Extended Spectrum β-lactamase producing Enterobacteriaceae among food handlers in lower basic schools in West Coast Region of The Gambia.

Sanneh B, Kebbeh A, Jallow HS, Camara Y, Mwamakamba LW, Ceesay IF, Barrow E, Sowe FO, Sambou SM, Baldeh I, Jallow A, Jorge Raul MA, Andremont A.

PLoS One. 2018 Aug 13;13(8):e0200894. doi: 10.1371/journal.pone.0200894. eCollection 2018.

2.

High acquisition rate of extended-spectrum β-lactamase-producing Enterobacteriaceae among French military personnel on mission abroad, without evidence of inter-individual transmission.

Maataoui N, Mayet A, Duron S, Delacour H, Mentré F, Laouenan C, Desvillechabrol D, Cokelaer T, Meynard JB, Ducher A, Andremont A, Armand-Lefèvre L, Mérens A.

Clin Microbiol Infect. 2018 Aug 9. pii: S1198-743X(18)30561-5. doi: 10.1016/j.cmi.2018.07.030. [Epub ahead of print]

PMID:
30099136
3.

Antibiotic-Induced Dysbiosis Predicts Mortality in an Animal Model of Clostridium difficile Infection.

Burdet C, Sayah-Jeanne S, Nguyen TT, Hugon P, Sablier-Gallis F, Saint-Lu N, Corbel T, Ferreira S, Pulse M, Weiss W, Andremont A, Mentré F, de Gunzburg J.

Antimicrob Agents Chemother. 2018 Sep 24;62(10). pii: e00925-18. doi: 10.1128/AAC.00925-18. Print 2018 Oct.

PMID:
30061286
4.

Critical knowledge gaps and research needs related to the environmental dimensions of antibiotic resistance.

Larsson DGJ, Andremont A, Bengtsson-Palme J, Brandt KK, de Roda Husman AM, Fagerstedt P, Fick J, Flach CF, Gaze WH, Kuroda M, Kvint K, Laxminarayan R, Manaia CM, Nielsen KM, Plant L, Ploy MC, Segovia C, Simonet P, Smalla K, Snape J, Topp E, van Hengel AJ, Verner-Jeffreys DW, Virta MPJ, Wellington EM, Wernersson AS.

Environ Int. 2018 Aug;117:132-138. doi: 10.1016/j.envint.2018.04.041. Epub 2018 May 7.

5.

Travel and acquisition of multidrug-resistant Enterobacteriaceae.

Armand-Lefèvre L, Andremont A, Ruppé E.

Med Mal Infect. 2018 Oct;48(7):431-441. doi: 10.1016/j.medmal.2018.02.005. Epub 2018 Mar 14. Review.

PMID:
29550142
6.

In-depth resistome analysis by targeted metagenomics.

Lanza VF, Baquero F, Martínez JL, Ramos-Ruíz R, González-Zorn B, Andremont A, Sánchez-Valenzuela A, Ehrlich SD, Kennedy S, Ruppé E, van Schaik W, Willems RJ, de la Cruz F, Coque TM.

Microbiome. 2018 Jan 15;6(1):11. doi: 10.1186/s40168-017-0387-y.

7.

Isolation in small populations of Wayampi Amerindians promotes endemicity and homogenisation of their faecal virome, but its distribution is not entirely random.

Pérez-Brocal V, Andremont A, Moya A.

FEMS Microbiol Ecol. 2018 Feb 1;94(2). doi: 10.1093/femsec/fix184.

PMID:
29272453
8.

Protection of the Human Gut Microbiome From Antibiotics.

de Gunzburg J, Ghozlane A, Ducher A, Le Chatelier E, Duval X, Ruppé E, Armand-Lefevre L, Sablier-Gallis F, Burdet C, Alavoine L, Chachaty E, Augustin V, Varastet M, Levenez F, Kennedy S, Pons N, Mentré F, Andremont A.

J Infect Dis. 2018 Jan 30;217(4):628-636. doi: 10.1093/infdis/jix604.

9.

Digestive tract colonization by multidrug-resistant Enterobacteriaceae in travellers: An update.

Ruppé E, Andremont A, Armand-Lefèvre L.

Travel Med Infect Dis. 2018 Jan - Feb;21:28-35. doi: 10.1016/j.tmaid.2017.11.007. Epub 2017 Nov 17. Review.

PMID:
29155322
10.

Universal or targeted approach to prevent the transmission of extended-spectrum beta-lactamase-producing Enterobacteriaceae in intensive care units: a cost-effectiveness analysis.

Kardaś-Słoma L, Lucet JC, Perozziello A, Pelat C, Birgand G, Ruppé E, Boëlle PY, Andremont A, Yazdanpanah Y.

BMJ Open. 2017 Nov 3;7(11):e017402. doi: 10.1136/bmjopen-2017-017402.

11.

Too Early to Recommend Early Fecal Microbiota Transplantation in Patients With Severe Clostridium difficile Infection, or Not Too Early?

Andremont A.

Clin Infect Dis. 2018 Feb 10;66(5):651-652. doi: 10.1093/cid/cix763. No abstract available.

PMID:
29020240
12.

Impact of antibiotics on the intestinal microbiota needs to be re-defined to optimize antibiotic usage.

Ruppé E, Burdet C, Grall N, de Lastours V, Lescure FX, Andremont A, Armand-Lefèvre L.

Clin Microbiol Infect. 2018 Jan;24(1):3-5. doi: 10.1016/j.cmi.2017.09.017. Epub 2017 Sep 29. No abstract available.

PMID:
28970162
13.

Burden of Clostridium difficile Infections in French Hospitals in 2014 From the National Health Insurance Perspective.

Leblanc S, Blein C, Andremont A, Bandinelli PA, Galvain T.

Infect Control Hosp Epidemiol. 2017 Aug;38(8):906-911. doi: 10.1017/ice.2017.114.

PMID:
28756805
14.

Protection of Hamsters from Mortality by Reducing Fecal Moxifloxacin Concentration with DAV131A in a Model of Moxifloxacin-Induced Clostridium difficile Colitis.

Burdet C, Sayah-Jeanne S, Nguyen TT, Miossec C, Saint-Lu N, Pulse M, Weiss W, Andremont A, Mentré F, de Gunzburg J.

Antimicrob Agents Chemother. 2017 Sep 22;61(10). pii: e00543-17. doi: 10.1128/AAC.00543-17. Print 2017 Oct.

15.

Cefazolin versus anti-staphylococcal penicillins for treatment of methicillin-susceptible Staphylococcus aureus bacteraemia: a narrative review.

Loubet P, Burdet C, Vindrios W, Grall N, Wolff M, Yazdanpanah Y, Andremont A, Duval X, Lescure FX.

Clin Microbiol Infect. 2018 Feb;24(2):125-132. doi: 10.1016/j.cmi.2017.07.003. Epub 2017 Jul 8. Review.

16.

Prevalence of extended-spectrum beta-lactamase phenotypes in enterobacteria isolated from blood cultures of patients at admission to the University Hospital of Bamako.

Sangaré SA, Maïga AI, Maïga A, Diallo S, Camara N, Savadogo S, Guindo I, Bougoudogo F, Armand-Lefèvre L, Andremont A, Maïga II.

Med Sante Trop. 2017 Jun 1;27(2):170-175. doi: 10.1684/mst.2017.0681.

17.

Travel-acquired ESBL-producing Enterobacteriaceae: impact of colonization at individual and community level.

Woerther PL, Andremont A, Kantele A.

J Travel Med. 2017 Apr 1;24(suppl_1):S29-S34. doi: 10.1093/jtm/taw101. Review.

18.

Unexpected persistence of extended-spectrum β-lactamase-producing Enterobacteriaceae in the faecal microbiota of hospitalised patients treated with imipenem.

Grall N, Lazarevic V, Gaïa N, Couffignal C, Laouénan C, Ilic-Habensus E, Wieder I, Plesiat P, Angebault C, Bougnoux ME, Armand-Lefevre L, Andremont A, Duval X, Schrenzel J.

Int J Antimicrob Agents. 2017 Jul;50(1):81-87. doi: 10.1016/j.ijantimicag.2017.02.018. Epub 2017 May 10.

PMID:
28499958
19.

Day-to-Day Dynamics of Commensal Escherichia coli in Zimbabwean Cows Evidence Temporal Fluctuations within a Host-Specific Population Structure.

Massot M, Couffignal C, Clermont O, D'Humières C, Chatel J, Plault N, Andremont A, Caron A, Mentré F, Denamur E.

Appl Environ Microbiol. 2017 Jun 16;83(13). pii: e00659-17. doi: 10.1128/AEM.00659-17. Print 2017 Jul 1.

20.

Towards a research agenda for water, sanitation and antimicrobial resistance.

Wuijts S, van den Berg HH, Miller J, Abebe L, Sobsey M, Andremont A, Medlicott KO, van Passel MW, de Roda Husman AM.

J Water Health. 2017 Apr;15(2):175-184. doi: 10.2166/wh.2017.124.

PMID:
28362299
21.

Very high prevalence of extended-spectrum beta-lactamase-producing Enterobacteriaceae in bacteriemic patients hospitalized in teaching hospitals in Bamako, Mali.

Sangare SA, Rondinaud E, Maataoui N, Maiga AI, Guindo I, Maiga A, Camara N, Dicko OA, Dao S, Diallo S, Bougoudogo F, Andremont A, Maiga II, Armand-Lefevre L.

PLoS One. 2017 Feb 28;12(2):e0172652. doi: 10.1371/journal.pone.0172652. eCollection 2017.

22.

Microbiote intestinal : qu’en attendre au plan physiologique et thérapeutique ?

Doré J, Multon MC, Béhier JM; les participants à la table ronde 2 des Ateliers de Giens XXXII, Affagard H, Andremont A, Barthélémy P, Batista R, Bonneville M, Bonny C, Boyaval G, Chamaillard M, Chevalier MP, Cordaillat-Simmons M, Cournarie F, Diaz I, Guillaume E, Guyard C, Jouvin-Marche E, Martin FP, Petiteau D.

Therapie. 2017 Feb;72(1):1-19. doi: 10.1016/j.therap.2017.01.001. Epub 2017 Jan 11. French. No abstract available.

PMID:
28214070
23.

Reply to Cohen and Denning.

Collignon PJ, Conly JM, Andremont A, McEwen SA, Aidara-Kane A.

Clin Infect Dis. 2017 Apr 1;64(7):987-988. doi: 10.1093/cid/cix061. No abstract available.

PMID:
28158496
24.

First report of human infection due to Streptococcus devriesei.

Tammaro P, Richard N, Andre B, Andremont A, Mammeri H.

New Microbes New Infect. 2016 Nov 15;15:72-73. doi: 10.1016/j.nmni.2016.11.009. eCollection 2017 Jan.

25.

Intestinal carriage of Extended Spectrum Beta-Lactamase producing E. coli in women with urinary tract infections, Cameroon.

Djuikoue IC, Woerther PL, Toukam M, Burdet C, Ruppé E, Gonsu KH, Fokunang C, El Mniai A, Larissa K, Pieme AC, Mboupaing MG, Kakam CM, Fogang HK, Andremont A, Ngogang J.

J Infect Dev Ctries. 2016 Oct 31;10(10):1135-1139. doi: 10.3855/jidc.7616.

26.

Prevalence of ESBL-producing Enterobacteriaceae isolated from blood cultures in Mali.

Sangare SA, Maiga AI, Guindo I, Maiga A, Camara N, Dicko OA, Diallo S, Bougoudogo F, Armand-Lefevre L, Andremont A, Maiga II.

J Infect Dev Ctries. 2016 Oct 31;10(10):1059-1064. doi: 10.3855/jidc.7536.

27.

ESBL-producing Enterobacteriaceae in travellers: doctors beware.

Armand-Lefevre L, Ruppé E, Andremont A.

Lancet Infect Dis. 2017 Jan;17(1):8-9. doi: 10.1016/S1473-3099(16)30417-0. Epub 2016 Oct 14. No abstract available.

PMID:
27751773
28.

World Health Organization Ranking of Antimicrobials According to Their Importance in Human Medicine: A Critical Step for Developing Risk Management Strategies to Control Antimicrobial Resistance From Food Animal Production.

Collignon PJ, Conly JM, Andremont A, McEwen SA, Aidara-Kane A; World Health Organization Advisory Group, Bogotá Meeting on Integrated Surveillance of Antimicrobial Resistance (WHO-AGISAR), Agerso Y, Andremont A, Collignon P, Conly J, Dang Ninh T, Donado-Godoy P, Fedorka-Cray P, Fernandez H, Galas M, Irwin R, Karp B, Matar G, McDermott P, McEwen S, Mitema E, Reid-Smith R, Scott HM, Singh R, DeWaal CS, Stelling J, Toleman M, Watanabe H, Woo GJ.

Clin Infect Dis. 2016 Oct 15;63(8):1087-1093. doi: 10.1093/cid/ciw475. Epub 2016 Jul 20. Review. Erratum in: Clin Infect Dis. 2016 Dec 1;63(11):1536.

PMID:
27439526
29.

Prevention of urinary tract infections by antibiotic cycling in spinal cord injury patients and low emergence of multidrug resistant bacteria.

Poirier C, Dinh A, Salomon J, Grall N, Andremont A, Bernard L.

Med Mal Infect. 2016 Sep;46(6):294-9. doi: 10.1016/j.medmal.2016.02.010. Epub 2016 Jun 16.

PMID:
27321478
30.

Impact of a short exposure to levofloxacin on faecal densities and relative abundance of total and quinolone-resistant Enterobacteriaceae.

Bernard J, Armand-Lefèvre L, Luce E, El Mniai A, Chau F, Casalino E, Andremont A, Ruppé E.

Clin Microbiol Infect. 2016 Jul;22(7):646.e1-4. doi: 10.1016/j.cmi.2016.04.015. Epub 2016 Apr 26.

31.

Dissemination of the mcr-1 colistin resistance gene.

Ruppé E, Le Chatelier E, Pons N, Andremont A, Ehrlich SD.

Lancet Infect Dis. 2016 Mar;16(3):290-1. doi: 10.1016/S1473-3099(16)00066-9. No abstract available.

PMID:
26973305
32.

Escherichia coli Population Structure and Antibiotic Resistance at a Buffalo/Cattle Interface in Southern Africa.

Mercat M, Clermont O, Massot M, Ruppe E, de Garine-Wichatitsky M, Miguel E, Valls Fox H, Cornelis D, Andremont A, Denamur E, Caron A.

Appl Environ Microbiol. 2015 Dec 28;82(5):1459-1467. doi: 10.1128/AEM.03771-15.

33.

Hand Hygiene, Cohorting, or Antibiotic Restriction to Control Outbreaks of Multidrug-Resistant Enterobacteriaceae.

Pelat C, Kardaś-Słoma L, Birgand G, Ruppé E, Schwarzinger M, Andremont A, Lucet JC, Yazdanpanah Y.

Infect Control Hosp Epidemiol. 2016 Mar;37(3):272-80. doi: 10.1017/ice.2015.284. Epub 2015 Dec 28.

PMID:
26708383
34.

Emergence of Antimicrobial-Resistant Escherichia coli of Animal Origin Spreading in Humans.

Skurnik D, Clermont O, Guillard T, Launay A, Danilchanka O, Pons S, Diancourt L, Lebreton F, Kadlec K, Roux D, Jiang D, Dion S, Aschard H, Denamur M, Cywes-Bentley C, Schwarz S, Tenaillon O, Andremont A, Picard B, Mekalanos J, Brisse S, Denamur E.

Mol Biol Evol. 2016 Apr;33(4):898-914. doi: 10.1093/molbev/msv280. Epub 2015 Nov 26.

35.

Carriage of Enterobacteria Producing Extended-Spectrum β-Lactamases and Composition of the Gut Microbiota in an Amerindian Community.

Gosalbes MJ, Vázquez-Castellanos JF, Angebault C, Woerther PL, Ruppé E, Ferrús ML, Latorre A, Andremont A, Moya A.

Antimicrob Agents Chemother. 2015 Nov 9;60(1):507-14. doi: 10.1128/AAC.01528-15. Print 2016 Jan.

36.

Prevalence of extended-spectrum beta-lactamase-producing Enterobacteriaceae isolated from blood cultures in Africa.

Sangare SA, Maiga AI, Guindo I, Maiga A, Camara N, Savadogo S, Diallo S, Bougoudogo F, Armand-Lefevre L, Andremont A, Maiga II.

Med Mal Infect. 2015 Sep;45(9):374-82. doi: 10.1016/j.medmal.2015.08.003. Review.

PMID:
26433872
37.

Reply to Collignon and Kennedy.

Ruppé E, Armand-Lefèvre L, Estellat C, Coignard B, Lucet JC, Andremont A, Matheron S.

Clin Infect Dis. 2015 Dec 1;61(11):1767. doi: 10.1093/cid/civ705. Epub 2015 Aug 13. No abstract available.

PMID:
26276883
38.

What to do about resistant bacteria in the food-chain?

Andremont A, Fiona Fleck.

Bull World Health Organ. 2015 Apr 1;93(4):217-8. doi: 10.2471/BLT.15.030415.

39.

Antibiotic cycling prevents urinary tract infections in spinal cord injury patients and limits the emergence of multidrug resistant organism.

Poirier C, Dinh A, Salomon J, Grall N, Andremont A, Bernard L.

J Infect. 2015 Oct;71(4):491-3. doi: 10.1016/j.jinf.2015.06.001. Epub 2015 Jun 18. No abstract available.

PMID:
26093047
40.

High Rate of Acquisition but Short Duration of Carriage of Multidrug-Resistant Enterobacteriaceae After Travel to the Tropics.

Ruppé E, Armand-Lefèvre L, Estellat C, Consigny PH, El Mniai A, Boussadia Y, Goujon C, Ralaimazava P, Campa P, Girard PM, Wyplosz B, Vittecoq D, Bouchaud O, Le Loup G, Pialoux G, Perrier M, Wieder I, Moussa N, Esposito-Farèse M, Hoffmann I, Coignard B, Lucet JC, Andremont A, Matheron S.

Clin Infect Dis. 2015 Aug 15;61(4):593-600. doi: 10.1093/cid/civ333. Epub 2015 Apr 22.

PMID:
25904368
41.

Lack of dissemination of acquired resistance to β-lactams in small wild mammals around an isolated village in the Amazonian forest.

Grall N, Barraud O, Wieder I, Hua A, Perrier M, Babosan A, Gaschet M, Clermont O, Denamur E, Catzeflis F, Decré D, Ploy MC, Andremont A.

Environ Microbiol Rep. 2015 Oct;7(5):698-708. doi: 10.1111/1758-2229.12289. Epub 2015 Jun 10.

PMID:
25858231
42.

Performance and impact of a rapid method combining mass spectrometry and direct antimicrobial susceptibility testing on treatment adequacy of patients with ventilator-associated pneumonia.

Le Dorze M, Gault N, Foucrier A, Ruppé E, Mourvillier B, Woerther PL, Birgand G, Montravers P, Dilly MP, Tubach F, Andremont A, Timsit JF, Wolff M, Armand-Lefèvre L.

Clin Microbiol Infect. 2015 May;21(5):468.e1-6. doi: 10.1016/j.cmi.2014.12.007. Epub 2014 Dec 26.

43.

Prolonged hospital stay, an adverse effect of strict national policy for controlling the spread of highly resistant microorganisms.

Birgand G, Schwarzinger M, Perozziello A, Lolom I, Pelat C, Armand-Lefevre L, Buzzi JC, Andremont A, Yazdanpanah Y, Lucet JC.

Infect Control Hosp Epidemiol. 2014 Nov;35(11):1427-9. doi: 10.1086/678425. Epub 2014 Oct 2. No abstract available.

PMID:
25333442
44.

Mathematical modeling of bacterial kinetics to predict the impact of antibiotic colonic exposure and treatment duration on the amount of resistant enterobacteria excreted.

Nguyen TT, Guedj J, Chachaty E, de Gunzburg J, Andremont A, Mentré F.

PLoS Comput Biol. 2014 Sep 11;10(9):e1003840. doi: 10.1371/journal.pcbi.1003840. eCollection 2014 Sep.

45.

Introduction of highly resistant bacteria into a hospital via patients repatriated or recently hospitalized in a foreign country.

Birgand G, Armand-Lefevre L, Lepainteur M, Lolom I, Neulier C, Reibel F, Yazdanpanah Y, Andremont A, Lucet JC.

Clin Microbiol Infect. 2014 Nov;20(11):O887-90. doi: 10.1111/1469-0691.12604. Epub 2014 Mar 21.

46.

Targeted adsorption of molecules in the colon with the novel adsorbent-based medicinal product, DAV132: A proof of concept study in healthy subjects.

de Gunzburg J, Ducher A, Modess C, Wegner D, Oswald S, Dressman J, Augustin V, Feger C, Andremont A, Weitschies W, Siegmund W.

J Clin Pharmacol. 2015 Jan;55(1):10-6. doi: 10.1002/jcph.359. Epub 2014 Jul 16.

PMID:
25042595
47.

Acquisition of carbapenemase-producing Enterobacteriaceae by healthy travellers to India, France, February 2012 to March 2013.

Ruppé E, Armand-Lefèvre L, Estellat C, El-Mniai A, Boussadia Y, Consigny PH, Girard PM, Vittecoq D, Bouchaud O, Pialoux G, Esposito-Farèse M, Coignard B, Lucet JC, Andremont A, Matheron S.

Euro Surveill. 2014 Apr 10;19(14). pii: 20768.

48.

The emergence of linezolid resistance among Enterococci in intestinal microbiota of treated patients is unrelated to individual pharmacokinetic characteristics.

Bourgeois-Nicolaos N, Nguyen TT, Defrance G, Massias L, Alavoine L, Lefort A, Noel V, Senneville E, Doucet-Populaire F, Mentré F, Andremont A, Duval X.

Antimicrob Agents Chemother. 2014 May;58(5):2681-7. doi: 10.1128/AAC.02251-13. Epub 2014 Feb 24.

49.

Ventilator-associated pneumonia due to carbapenem-resistant Gram-negative bacilli in an intensive care unit without carbapenemase-producing Enterobacteriaceae or epidemic Acinetobacter baumannii.

Soubirou JF, Gault N, Alfaiate T, Lolom I, Tubach F, Andremont A, Lucet JC, Wolff M, Barbier F.

Scand J Infect Dis. 2014 Mar;46(3):215-20. doi: 10.3109/00365548.2013.871644. Epub 2014 Jan 21.

PMID:
24447250
50.

Enterobacteriaceae bacteremia: risk factors for ESBLPE.

Neulier C, Birgand G, Ruppé É, Armand-Lefèvre L, Lolom I, Yazdanpanah Y, Lucet JC, Andremont A.

Med Mal Infect. 2014 Jan;44(1):32-8. doi: 10.1016/j.medmal.2013.11.003. Epub 2013 Dec 8.

PMID:
24321202

Supplemental Content

Loading ...
Support Center